Drupal.behaviors.print = function(context) {window.print();window.close();}>
Epigenomics' Q1 Revenues Fall 67 Percent
May 09, 2012
Epigenomics' Q1 Revenues Fall 67 Percent
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Epigenomics' Q2 Revenues Tumble 57 Percent
August 8, 2012 / GenomeWeb Daily News
Epigenomics' Q3 Revenues Fall 29 Percent; PMA Submission Targeted for Epi proColon 2.0
November 9, 2011 / GenomeWeb Daily News
Epigenomics' Nine-Month Revenues Drop Sharply
November 9, 2010 / GenomeWeb Daily News
Vermillion's OVA1 Sales Increase 8 Percent in Q1
May 16, 2013 / GenomeWeb Daily News
Cancer Genetics Reports 45 Percent Increase in Q1 Revenues, Maps out Growth Strategy
May 16, 2013 / GenomeWeb Daily News